Furthermore, increasing studies have also marked CaMK II as a determinant of clinically important heart disease phenotypes, and suggest the inhibition of CaMK II can be a highly selective approach for targeting adverse myocardial remodeling linked to β-AR signaling55. This evidence concerns the gene CAMK2G and heart disorder.